Serum Prolidase Activity, Oxidative Stress, and Antioxidant Enzyme Levels in Patients With Prostate Cancer
dc.authorid | Verep, Samed/0000-0002-1086-6380 | |
dc.authorscopusid | 24334938700 | |
dc.authorscopusid | 9244561200 | |
dc.authorscopusid | 56259656000 | |
dc.authorscopusid | 56690366700 | |
dc.authorwosid | Verep, Samed/Abb-4461-2021 | |
dc.contributor.author | Kaba, Mehmet | |
dc.contributor.author | Pirincci, Necip | |
dc.contributor.author | Demir, Halit | |
dc.contributor.author | Verep, Samed | |
dc.date.accessioned | 2025-05-10T17:23:54Z | |
dc.date.available | 2025-05-10T17:23:54Z | |
dc.date.issued | 2024 | |
dc.department | T.C. Van Yüzüncü Yıl Üniversitesi | en_US |
dc.department-temp | [Kaba, Mehmet; Verep, Samed] Private Yuzyil Gebze Hosp, Dept Urol, Kocaeli, Turkiye; [Pirincci, Necip] Firat Univ, Med Fac, Dept Urol, Elazig, Turkiye; [Demir, Halit] Van Yuzuncuyil Univ, Sci Fac, Dept Chem, Van, Turkiye | en_US |
dc.description | Verep, Samed/0000-0002-1086-6380 | en_US |
dc.description.abstract | Objectives: We aimed to identify serum prolidase activity, oxidative stress, and antioxidant enzyme levels in patients with prostate cancers and to evaluate their relationships with each other. Materials and methods: A total of 34 male patients with prostate cancer and with a mean age of 64.2 +/- 4.4 were included in the study. The control group comprising 36 male patients (mean age 61.2 +/- 3.4) was randomly selected among the volunteers. Serum samples for measurement of superoxide dismutase (SOD), glutathione peroxidase (GPx), Catalase (CAT), malondialdehyde (MDA), glutathione (GSH), and prolidase levels were kept at -20 & ring;C until they were used. Results: Serum prolidase activity and MDA levels were significantly higher in prostate cancer patients than in controls (all, P < 0.05), while SOD, GPx, and CAT levels were significantly lower (P < 0.05). Conclusion: Our results indicate that increased prolidase seems to be related to increased oxidative stress along with decreased antioxidant levels in prostate cancer. (c) 2024 Elsevier Inc. All rights reserved. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.1016/j.urolonc.2024.01.007 | |
dc.identifier.endpage | 1.16E+017 | en_US |
dc.identifier.issn | 1078-1439 | |
dc.identifier.issn | 1873-2496 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 38341363 | |
dc.identifier.scopus | 2-s2.0-85184780002 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 116000000000 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.urolonc.2024.01.007 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14720/11025 | |
dc.identifier.volume | 42 | en_US |
dc.identifier.wos | WOS:001225886100001 | |
dc.identifier.wosquality | N/A | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier Science inc | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Prostate Cancer | en_US |
dc.subject | Prolidase Activity | en_US |
dc.subject | Antioxidant Enzyme | en_US |
dc.title | Serum Prolidase Activity, Oxidative Stress, and Antioxidant Enzyme Levels in Patients With Prostate Cancer | en_US |
dc.type | Article | en_US |